相关实验视频
Updated: May 25, 2025
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
6.9K
SLC26A2的诊断意义及其在性结肠炎中的潜在作用
Lijuan Qian1, Shuo Hu2, Haizhou Zhao2
1Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Biomedicines
|February 26, 2025
概括
溶性载体家族26号,2号成员 (SLC26A2) 在性结肠炎 (UC) 中下调,与疾病严重程度相关. 向SLC26A2显示了新的UC治疗的潜力.
科学领域:
- 遗传学和分子生物学
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 在性结肠炎 (UC) 中,溶解物载体家族26 (SLC26A2) 2成员基因的作用尚不清楚.
- 有限的研究存在于SLC26A2在结肠相关疾病的功能,特别是UC.
研究的目的:
- 使用生物信息学分析识别UC候选基因.
- 阐明SLC26A2在UC病变发生过程中的细胞特征和生物功能.
- 探索SLC26A2作为UC的潜在治疗点.
主要方法:
- 生物信息学分析以确定UC候选基因.
- 对UC患者和健康对照者的肠粘膜中SLC26A2表达的分析.
- 使用DSS诱导的UC小鼠模型进行体内验证.
- 在SLC26A2表达和UC临床特征之间的相关性分析.
- 预测潜在的药物针对SLC26A2进行UC治疗.
主要成果:
- 在活跃UC患者和UC小鼠模型中,SLC26A2的下调显著.
- 降低的SLC26A2水平与UC严重程度相关 (梅奥得分,PUCAI) 并具有诊断性.
- SLC26A2与IL-17信号负相关,与紧密结正相关,影响免疫透.
- 在结肠组织中,SLC26A2与CLDN3正相关,与IL-17A负相关.
- 预测的药物如孕激素,四氧化和德克萨米他通过SLC26A2.2.表现出抗炎作用.
结论:
- SLC26A2可能在UC病变发生过程中起着保护作用.
- SLC26A2代表了性结肠炎治疗的潜在治疗标.
- 对SLC26A2调制的进一步研究可能会导致新的UC疗法.
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
112
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
112
01:29Drugs for Treatment of Ulcerative Colitis in IBD
118
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
118
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
294
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
294
01:30Inflammatory Bowel Disease II: Crohn's Disease
157
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
157
01:17Chronic Bowel Disorders: Introduction
378
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
378
01:33Pleiotropy
39.4K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
39.4K